Skip to content
Search

Latest Stories

RPS to host sessions to help shape response for NHS primary care review

The Royal Pharmaceutical Society (RPS) will be hosting two sessions for members to help them shape response to an NHS review of primary care in England.

The sessions will be held on March 15 and March 24 at 7.00pm and will be open to members working in all settings, including primary and secondary care, RPS stated.


The ‘Fuller Stocktake’ review is focusing on how best primary care, including community pharmacy, can be supported within the emergent Integrated Care Systems (ICSs) to meet the health needs of people in their local areas.

It will cover a range of issues, including:

  • Workforce, including leadership and education
  • Collection and use of data and information
  • Working with communities and how best to engage with them
  • Physical access to care
  • Non-physical access to care including use of technology and remote consultations
  • Governance and decision making which includes local contracting

Commenting on the review, RPS England chair Thorrun Govind said: “This review is an important part of how the government and NHS are examining the future of health and care in England.

“Whether it is delivering more integrated care, utilising new technologies, or developing our workforce, these reforms must have improving patient care at their heart.

“Pharmacists working right across the health service continue to put patients first and I know will play a key role in how we transform services for the future.

“These sessions will help inform our ongoing engagement with the NHS about the Fuller Stocktake and what this means alongside wider changes to the NHS.

“We want to hear from pharmacists working across care settings and I would encourage members to attend.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less